Citadel Advisors’s Hydrogenics Corp HYGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-14,600
Closed -$217K 10214
2019
Q2
$217K Buy
+14,600
New +$144K ﹤0.01% 8079
2016
Q2
Sell
-17,500
Closed -$143K 7968
2016
Q1
$143K Buy
+17,500
New +$137K ﹤0.01% 5860
2015
Q1
Sell
-4,800
Closed -$64K 9323
2014
Q4
$64K Sell
4,800
-2,700
-36% -$40.4K ﹤0.01% 7020
2014
Q3
$126K Buy
+7,500
New +$153K ﹤0.01% 6201

Citadel Advisors's HYGS Position: Q3 2016 in Review

Citadel Advisors sold out of Hydrogenics Corp (HYGS) in Q3 2016, closing a stake of 10,075 shares — an estimated $70K sold.

Citadel Advisors first reported a position in HYGS in Q3 2014 and held it in 3 quarters. The position peaked at $70K in Q2 2016. 35 funds tracked by Wall St. Rank hold HYGS as of Q3 2016.

  • Citadel Advisors reported no remaining Hydrogenics Corp position as of Q3 2016 after selling out during the quarter.
  • Citadel Advisors sold 10,075 Hydrogenics Corp shares in Q3 2016, an estimated $70K.
  • Citadel Advisors first reported a position in Hydrogenics Corp in Q3 2014 and held it in 3 quarters.
  • Citadel Advisors's Hydrogenics Corp position peaked at $70K in Q2 2016.
  • 35 funds tracked by Wall St. Rank held Hydrogenics Corp as of Q3 2016.

Based on Citadel Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.